Bristol Myers Squibb’s Opdivo posts another win in early lung cancer, but debate over treatment approach likely remainsnews2021-11-08T15:08:21+00:00November 8th, 2021|Fierce Pharma|
Regeneron’s antibody cocktail can protect against COVID-19 for up to 8 months, giving hope to the immunocompromisednews2021-11-08T14:31:04+00:00November 8th, 2021|Fierce Pharma|
Regeneron’s antibody cocktail protects against COVID-19 for up to 8 months, giving hope to the immunocompromisednews2021-11-08T14:31:04+00:00November 8th, 2021|Fierce Pharma|
Japan’s Meiji Seika to build $20.1M manufacturing plant in Indianews2021-11-08T13:58:15+00:00November 8th, 2021|Fierce Pharma|
Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to comenews2021-11-08T12:51:04+00:00November 8th, 2021|Fierce Pharma|
Sanofi, Roche team up to drive adoption of smart insulin pennews2021-11-08T12:20:46+00:00November 8th, 2021|Fierce Pharma|
With subcut Darzalex driving growth, Halozyme eyes role for drug delivery tech in cell therapiesnews2021-11-08T12:17:37+00:00November 8th, 2021|Fierce Pharma|
Actress Jen Landon gets personal about losing her father, Michael Landon, to pancreatic cancer in new PSAnews2021-11-05T21:17:09+00:00November 5th, 2021|Fierce Pharma|
With oncology spinoff done, bluebird bio moves to new digs better suited to its futurenews2021-11-05T18:31:48+00:00November 5th, 2021|Fierce Pharma|
GlaxoSmithKline’s novel anemia drug succeeds where AstraZeneca-FibroGen, Akebia failednews2021-11-05T16:51:00+00:00November 5th, 2021|Fierce Pharma|
